Purchase Order 75N95023P00848

Medchemexpress LLC has been awarded a firm fixed price purchase order valued at $24,700 by the National Institutes of Health's National Center for Advancing Translational Sciences to provide 29 compounds in support of the agency's Tox21 research project examining the NS3-NS2B complex. As part of its mission to translate scientific discoveries into clinical applications, NCATS utilizes screening programs like Tox21 to evaluate the effects of environmental chemicals on biological pathways related to toxicity. This small business set-aside contract will deliver test substances over a three-month period to the prime contractor's facility in Monmouth Junction, New Jersey to facilitate NCATS' ongoing work in this therapeutic area.